Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin P Alyea

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
British Journal of Haematology|July 20, 2016
Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remissionAndrew M Brunner, Shuli Li, Amir T Fathi, et al.
JCO Precision Oncology|May 26, 2021
Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic SyndromeLaura W Dillon, Gege Gui, Brent R Logan, et al.
Cytotherapy|December 13, 2016
Lack of impact of umbilical cord blood unit processing techniques on clinical outcomes in adult double cord blood transplant recipientsSarah Nikiforow, Shuli Li, Karen Snow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2013
Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?Mitchell Sabloff, Ronald M Sobecks, Kwang Woo Ahn, et al.
Cell Reports|August 9, 2023
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapyPavan Bachireddy, Elham Azizi, Cassandra Burdziak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2019
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual DiseaseChristopher S Hourigan, Laura W Dillon, Gege Gui, et al.
Cell Reports|November 10, 2021
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapyPavan Bachireddy, Elham Azizi, Cassandra Burdziak, et al.
Blood|March 14, 2022
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AMLH Moses Murdock, Haesook T Kim, Nathan Denlinger, et al.
Blood Advances|September 1, 2019
Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and childrenJennifer S Whangbo, Haesook T Kim, Nikola Mirkovic, et al.
Blood Advances|July 21, 2019
Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantationMax Jan, Matthew J Leventhal, Elizabeth A Morgan, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
British Journal of Haematology|July 20, 2016
Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remissionAndrew M Brunner, Shuli Li, Amir T Fathi, et al.
JCO Precision Oncology|May 26, 2021
Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic SyndromeLaura W Dillon, Gege Gui, Brent R Logan, et al.
Cytotherapy|December 13, 2016
Lack of impact of umbilical cord blood unit processing techniques on clinical outcomes in adult double cord blood transplant recipientsSarah Nikiforow, Shuli Li, Karen Snow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2013
Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?Mitchell Sabloff, Ronald M Sobecks, Kwang Woo Ahn, et al.
Cell Reports|August 9, 2023
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapyPavan Bachireddy, Elham Azizi, Cassandra Burdziak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2019
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual DiseaseChristopher S Hourigan, Laura W Dillon, Gege Gui, et al.
Cell Reports|November 10, 2021
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapyPavan Bachireddy, Elham Azizi, Cassandra Burdziak, et al.
Blood|March 14, 2022
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AMLH Moses Murdock, Haesook T Kim, Nathan Denlinger, et al.
Blood Advances|September 1, 2019
Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and childrenJennifer S Whangbo, Haesook T Kim, Nikola Mirkovic, et al.
Blood Advances|July 21, 2019
Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantationMax Jan, Matthew J Leventhal, Elizabeth A Morgan, et al.
Pageof 18